NeuroBlate
Total Payments
$3.6M
Transactions
844
Doctors
18
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $278,356 | 73 | 3 |
| 2023 | $854,864 | 268 | 5 |
| 2021 | $817,480 | 150 | 3 |
| 2020 | $659,680 | 134 | 1 |
| 2019 | $787,107 | 158 | 1 |
| 2018 | $80,957 | 26 | 0 |
| 2017 | $134,965 | 35 | 12 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.6M | 844 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LAANTERN | Monteris Medical Corporation | $2.4M | 4 |
| REMASTER | Monteris Medical Corporation | $275,328 | 3 |
| Clinical Studies | Monteris Medical Corporation | $219,810 | 1 |
| Patient Preference | Monteris Medical Corporation | $136,243 | 0 |
| Analysis of gene expression profiling in banked blood samples to identify molecular and immune markers of effects of immune activation by LITT plus immune checkpoint inhibitors in glioblastoma by single cell analysis | Monteris Medical Corporation | $131,885 | 0 |
| Patient Preferences for Drug-Resistant Epilepsy Treatment Options | Monteris Medical Corporation | $76,510 | 0 |
| FLAG | Monteris Medical Corporation | $68,607 | 6 |
| TORCH | Monteris Medical Corporation | $60,000 | 0 |
| Recurrent Mets Study | Monteris Medical Corporation | $54,750 | 0 |
| PENSAR | Monteris Medical Corporation | $49,181 | 0 |
| The Role of Laser Interstitial Thermal Therapy in Brain Cancer Immunotherapy using a Preclinical Mouse Model | Monteris Medical Corporation | $46,884 | 0 |
| FLARE | Monteris Medical Corporation | $25,644 | 7 |
| Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma | Monteris Medical Corporation | $19,630 | 0 |
| rGBM Study | Monteris Medical Corporation | $18,800 | 0 |
| Mets -DCE | Monteris Medical Corporation | $8,000 | 0 |
| LASR--Fragile GBM | Monteris Medical Corporation | $2,560 | 0 |
| Research-Laboratory | Monteris Medical Corporation | $1,550 | 3 |
| LITT | Monteris Medical Corporation | $792.00 | 0 |
Top Doctors Receiving Payments for NeuroBlate
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Orlando, FL | $3.6M | 794 |
| , M.D | Neurological Surgery | Cleveland, OH | $15,393 | 8 |
| , MD, PHD | Neurological Surgery | Durham, NC | $12,413 | 16 |
| , M.D | Exclusive Provider Organization | New York, NY | $10,523 | 5 |
| , MD | Hematology & Oncology | Cleveland, OH | $6,143 | 2 |
| , MD | Neurological Surgery | Winston Salem, NC | $5,200 | 3 |
| , MD | Neurological Surgery | New Haven, CT | $3,000 | 2 |
| , M.D | Neurological Surgery | Houston, TX | $1,776 | 3 |
| , M.D | Diagnostic Radiology | Durham, NC | $693.00 | 1 |
| , M.D | Neurological Surgery | Baltimore, MD | $520.00 | 1 |
| , MD | Diagnostic Radiology | Tampa, FL | $450.00 | 1 |
| , M.D | Neurology | Charlottesville, VA | $100.00 | 1 |
| , M.D | Neurology | New York, NY | $23.00 | 1 |
| , MD, PHD | Neurological Surgery | New Haven, CT | $23.00 | 1 |
| , MD | Neurology | New Haven, CT | $23.00 | 1 |
| , MD | Neurological Surgery | New Haven, CT | $23.00 | 1 |
| , DO | Epilepsy | New Haven, CT | $23.00 | 1 |
| Roy Strowd | — | Winston Salem, NC | $17.50 | 1 |
| , MD | Medical Oncology | Winston Salem, NC | $17.50 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $3.6M
- Total Doctors 18
- Transactions 844
About NeuroBlate
NeuroBlate is a drug associated with $3.6M in payments to 18 healthcare providers, recorded across 844 transactions in the CMS Open Payments database. The primary manufacturer is Monteris Medical Corporation.
Payment data is available from 2017 to 2024. In 2024, $278,356 was paid across 73 transactions to 3 doctors.
The most common payment nature for NeuroBlate is "Unspecified" ($3.6M, 100.0% of total).
NeuroBlate is associated with 18 research studies, including "LAANTERN" ($2.4M).